Literature DB >> 19432888

Constitutive telomere length and gastric cancer risk: case-control analysis in Chinese Han population.

Xiaonan Liu1, Guoqiang Bao, Tingting Huo, Zizhong Wang, Xianli He, Guanglong Dong.   

Abstract

The shortening of telomeres may result in chromosome instability and thus promote tumorigenesis. Previous studies have demonstrated clear involvement of telomere shortening in the carcinogenesis of several malignancies. However, the association between constitutive telomere shortening and gastric cancer development has yet to be established. Therefore, in the present study, we measured average telomere length using quantitative real-time PCR in peripheral blood lymphocytes from a gastric cancer (GC) case-control study consisting of 396 cases and 378 controls. The results showed that GC patients had significantly shorter average telomere length than matched controls (mean +/- SD 0.89 +/- 0.19 vs 1.06 +/- 0.25, P < 0.001). We further categorized telomere length using the 50% value in the controls as a cut-off point and assessed the association between telomere length and GC risk using multivariate logistic regression analysis. We found that short telomere length was associated with a significantly increased GC risk (adjusted odds ratio = 2.14, 95% confidence interval = 1.52-2.93). Quartile stratification revealed a dose-response relationship between telomere shortening and GC risk (P for trend < 0.001). Stratified analysis showed that sex, age, and alcohol drinking, but not smoking and Helicobacter pylori infection, seem to have a modulating effect on the average telomere length in both cases and controls. We also found that telomere shortening and smoking had a significant joint effect on GC risk. Collectively, our findings provide the first evidence linking the short telomere length in peripheral blood lymphocytes to elevated GC risk, which warrants further investigation in other populations.

Entities:  

Mesh:

Year:  2009        PMID: 19432888     DOI: 10.1111/j.1349-7006.2009.01169.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  24 in total

1.  Leukocyte telomere length predicts overall survival in hepatocellular carcinoma treated with transarterial chemoembolization.

Authors:  Han-Qiang Liu; Jia-Ze An; Juan Liu; Ye-Fa Yang; Hong-Xin Zhang; Bin-Yu Zhao; Ji-Bin Li; Hu-Shan Yang; Zhi-Nan Chen; Jin-Liang Xing
Journal:  Carcinogenesis       Date:  2012-02-08       Impact factor: 4.944

Review 2.  Epidemiologic evidence for a role of telomere dysfunction in cancer etiology.

Authors:  Jennifer Prescott; Ingrid M Wentzensen; Sharon A Savage; Immaculata De Vivo
Journal:  Mutat Res       Date:  2011-07-02       Impact factor: 2.433

3.  Telomere length varies by DNA extraction method: implications for epidemiologic research.

Authors:  Julie M Cunningham; Ruth A Johnson; Kristin Litzelman; Halcyon G Skinner; Songwon Seo; Corinne D Engelman; Russell J Vanderboom; Grace W Kimmel; Ronald E Gangnon; Douglas L Riegert-Johnson; John A Baron; John D Potter; Robert Haile; Daniel D Buchanan; Mark A Jenkins; David N Rider; Stephen N Thibodeau; Gloria M Petersen; Lisa A Boardman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-09-09       Impact factor: 4.254

Review 4.  Leukocyte Telomere Length and Pancreatic Cancer Risk: Updated Epidemiologic Review.

Authors:  Samuel O Antwi; Gloria M Petersen
Journal:  Pancreas       Date:  2018-03       Impact factor: 3.327

5.  Telomere shortening occurs early during gastrocarcinogenesis.

Authors:  Yunchuan Mu; Qing Zhang; Linhang Mei; Xiaosun Liu; Weili Yang; Jiren Yu
Journal:  Med Oncol       Date:  2011-02-27       Impact factor: 3.064

6.  Telomere length and variation in telomere biology genes in individuals with osteosarcoma.

Authors:  Lisa Mirabello; Elliott G Richards; Linh M Duong; Kai Yu; Zhaoming Wang; Richard Cawthon; Sonja I Berndt; Laurie Burdett; Salma Chowdhury; Kedest Teshome; Chester Douglass; Sharon A Savage
Journal:  Int J Mol Epidemiol Genet       Date:  2010-11-23

Review 7.  Recent progress in dyskeratosis congenita.

Authors:  Nobuhiro Nishio; Seiji Kojima
Journal:  Int J Hematol       Date:  2010-10-01       Impact factor: 2.490

8.  Telomere length and pancreatic cancer: a case-control study.

Authors:  Halcyon G Skinner; Ronald E Gangnon; Kristin Litzelman; Ruth A Johnson; Suresh T Chari; Gloria M Petersen; Lisa A Boardman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10-23       Impact factor: 4.254

Review 9.  Telomere diseases.

Authors:  Rodrigo T Calado; Neal S Young
Journal:  N Engl J Med       Date:  2009-12-10       Impact factor: 91.245

10.  Telomere length and risk of melanoma, squamous cell carcinoma, and basal cell carcinoma.

Authors:  Gabriella M Anic; Vernon K Sondak; Jane L Messina; Neil A Fenske; Jonathan S Zager; Basil S Cherpelis; Ji-Hyun Lee; William J Fulp; Pearlie K Epling-Burnette; Jong Y Park; Dana E Rollison
Journal:  Cancer Epidemiol       Date:  2013-03-21       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.